[1]
K. Bidlan, C. P. K, N. K, and S. K. K, “QBD-Driven RP-HPLC Method Development and Validation for Ipragliflozin and Saxagliptin in Pharmaceutical Dosage Forms Following ICH Guidelines”, IJCPS, vol. 14, no. 01, pp. 23–29, Jan. 2026, doi: 10.30904/j.ijcps.2026.4915.